Video
2021 AUA Annual Meeting Preview: Prostate, Bladder, and Kidney Cancer
Author(s):
Video Player is loading.
Urology Times Co-Editor-in-Chief Michael S. Cookson, MD, MMHC, provides an in-depth preview of the 2021 American Urological Association Annual Meeting, covering the areas of prostate, bladder, and kidney cancer. In his overview, he highlights the plenary sessions, late-breaking abstracts, and other abstracts of interest in the field of genitourinary cancers. Cookson is a professor at the University of Oklahoma Health Sciences Center (OUHSC), where he is also chairman of the Department of Urology.
Related Videos
Study data point to gender disparities in oncology research citations
Matthew Galsky, MD, on patient selection for perioperative durvalumab/chemo in MIBC
Nitin Yerram, MD, highlights trial of 177Lu-PSMA-617 in localized prostate cancer
Nitin Yerram, MD, highlights new resource center for patients with renal cell carcinoma
Suzanne B. Merrill, MD, FACS, discusses rBCG and the NMIBC landscape
Neeraj Agarwal, MD, shares key takeaways from TALAPRO-2
Expert describes implications of neoadjuvant durvalumab approval in MIBC
Sima Porten, MD, on gene-environment interactions in bladder cancer development
How rBCG EAP could open up access for Anktiva in bladder cancer
Betty Wang, MD, recaps 3 key urologic cancer studies from EAU 2025
Related Content
